- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 75.91M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.82M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.96M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $52.97M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $16.95M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $16.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $156.43M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $107.58M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $17.07M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $58.38M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $58.7M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $76.97M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $20.66M |
| Current Assets restated | Q1 2026 · Mar 31, 2025 | $20.66M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $218.13M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $169.6M |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $169.6M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.37 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.57M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.26M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.1M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$9.38M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$9.09M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.94M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$7.04M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $599.81K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $886.8K |
| Stock Issued | Q1 2026 · Mar 31, 2025 | 1.84M sh |